Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

The Novel Proteasome Inhibitor MLN2238 (Ixazomib) Induces Death In CLL Cells In Vitro and Potentiates Lethality Of Fludarabine and The BCL2 Inhibitor At-101

Kasyapa S. Chitta, PhD, Aneel Paulus, MD, MS, Sharoon Akhtar, Maja Kuranz, Kena Miller, A.R.N.P, Candido E. Rivera, MD, Vivek Roy, M.D., James M. Foran, MD, Aisha Masood, MD, Asher Chanan-Khan, MD

Blood (2013) 122 (21): 4189.

https://doi.org/10.1182/blood.V122.21.4189.4189

Published: 2013

Journal Articles

Waldenströms Macroglobulinemia Cell Lines Display Differential Surface Molecule Expression Reflecting Variability In Disease Biology and Potential Impact Of Therapeutic Stress

Aneel Paulus, MD, MS, Kasyapa S. Chitta, PhD, Sharoon Akhtar, Maja Kuranz, Paul K. Wallace, MS, PhD, Sikander Ailawadhi, M.D., Kena Miller, A.R.N.P, Candido E. Rivera, MD, Gerardo Colon-Otero, MD, Vivek Roy, M.D., Stephen M Ansell, M.D.Ph.D., Anne J. Novak, PhD, Peter Martin, MD, Morton Coleman, MD, Asher Chanan-Khan, MD

Blood (2013) 122 (21): 5091.

https://doi.org/10.1182/blood.V122.21.5091.5091

Published: 2013

Journal Articles

Novel Proteasome Inhibitors Induce Mitochondrial Destabilization and Activate Caspase Mediated Apoptosis In Preclinical Models Of Pediatric B-Cell Cancers

Aneel Paulus, MD, MS, Kasyapa S. Chitta, PhD, Eric Sandler, MD, Sharoon Akhtar, Maja Kuranz, Han Tun, MD, Vivek Roy, M.D., James M. Foran, MD, Kena Miller, A.R.N.P, Candido E. Rivera, MD, Asher Chanan-Khan, MD

Blood (2013) 122 (21): 5140.

https://doi.org/10.1182/blood.V122.21.5140.5140

Published: 2013

Journal Articles

Development Of a Human IgM Secreting Model Of Rpci-WM1 Through Xenografting In SCID Mice For In Vivo Drug Evaluation

Kasyapa S. Chitta, PhD, Aneel Paulus, MD, MS, Sharoon Akhtar, Maja Kuranz, Sikander Ailawadhi, M.D., Kena Miller, A.R.N.P, Candido E. Rivera, MD, Gerardo Colon-Otero, MD, Vivek Roy, M.D., Stephen M Ansell, M.D, Ph.D., Anne J. Novak, PhD, Peter Martin, MD, Morton Coleman, MD, Asher Chanan-Khan, MD

Blood (2013) 122 (21): 3081.

https://doi.org/10.1182/blood.V122.21.3081.3081

Published: 2013

Journal Articles

International Staging System (ISS) Is Superior to Durie-Salmon (DS) Staging in Predicting Overall Mortality in Multiple Myeloma (MM)

Sikander Ailawadhi, Taimur Sher, Mehul Patel, Lyudmyla Derby, Terry Mashtare, Gregory E. Wilding, Kena Miller, Alice Mohr, Kelvin Lee, Asher A. Chanan-Khan

Blood (2008) 112 (11): 2745.

https://doi.org/10.1182/blood.V112.11.2745.2745

Published: 2008

Journal Articles

Phase I Study of IMGN901 in Patients with Relapsed and Relapsed/Refractory CD56-Positive Multiple Myeloma

Asher Alban Chanan-Khan, MD, Mecide Gharibo, MD, Sundar Jagannath, MD, Nikhil C. Munshi, MD, Kenneth C Anderson, MD, Dawn DePaolo, Kelvin P. Lee, MD, Kena Miller, RN, MSN, FNP, Robin Guild, Sybil Zildjian, Albert Qin

Blood (2008) 112 (11): 3689.

https://doi.org/10.1182/blood.V112.11.3689.3689

Published: 2008

Journal Articles

Lenalidomide Associated Tumor Flare Reaction Correlates with Clinical Response in Patients with Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia

Taimur Sher, Mehul Patel, Amy Whitworth, Kena Miller, Laurie Musial, David Lawrence, Swaminathan Padmanabhan, Sikander Ailawadhi, Gregory Wilding, Dawn DePaolo, Naveen Bangia, Myron S. Czuczman, MD, Paul K. Wallace, MS, PhD, Kelvin P. Lee, MD, Asher Chanan Khan

Blood (2008) 112 (11): 4163.

https://doi.org/10.1182/blood.V112.11.4163.4163

Published: 2008

Journal Articles

Low Incidence of Deletions of ATM (ataxia-telangiectasia mutated) Gene in Patients (pts) with Multiple Myeloma (MM) as Detected by FISH.

Asher Alban Chanan-Khan, MD, Kena Miller, NP, Philip McCarthy, MD, Joanna M. Panasiewicz, AnneMarie W. Block, Ph.D.

Blood (2004) 104 (11): 4886.

https://doi.org/10.1182/blood.V104.11.4886.4886

Published: 2004

Journal Articles

Thalidomide (T) in Combination with Fludarabine (F) as Initial Therapy for Patients (pts) with Treatment Naïve Chronic Lymphocytic Leukemia (CLL): Results of a Phase I Trial.

Asher Alban Chanan-Khan, MD, Kena Miller, NP, Alexandra Koryzna, RN, Kenichi Takeshita, MD, Philip McCarthy, MD, Alice Mohr, NP, Kathleen Donohue, Zale P. Bernstein, MD, Arif Alam, MD, Myron S. Czuczman, MD

Blood (2004) 104 (11): 3476.

https://doi.org/10.1182/blood.V104.11.3476.3476

Published: 2004

NARROW

The Novel Proteasome Inhibitor MLN2238 (Ixazomib) Induces Death In CLL Cells In Vitro and Potentiates Lethality Of Fludarabine and The BCL2 Inhibitor At-101

Waldenströms Macroglobulinemia Cell Lines Display Differential Surface Molecule Expression Reflecting Variability In Disease Biology and Potential Impact Of Therapeutic Stress

Novel Proteasome Inhibitors Induce Mitochondrial Destabilization and Activate Caspase Mediated Apoptosis In Preclinical Models Of Pediatric B-Cell Cancers

Development Of a Human IgM Secreting Model Of Rpci-WM1 Through Xenografting In SCID Mice For In Vivo Drug Evaluation

International Staging System (ISS) Is Superior to Durie-Salmon (DS) Staging in Predicting Overall Mortality in Multiple Myeloma (MM)

Phase I Study of IMGN901 in Patients with Relapsed and Relapsed/Refractory CD56-Positive Multiple Myeloma

Lenalidomide Associated Tumor Flare Reaction Correlates with Clinical Response in Patients with Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia

Low Incidence of Deletions of ATM (ataxia-telangiectasia mutated) Gene in Patients (pts) with Multiple Myeloma (MM) as Detected by FISH.

Thalidomide (T) in Combination with Fludarabine (F) as Initial Therapy for Patients (pts) with Treatment Naïve Chronic Lymphocytic Leukemia (CLL): Results of a Phase I Trial.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only